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ABSTRACT
Background
Human papilloma virus (HPV) infection is implicated in the cause of  cervical cancer which is the second most 
common cancer in women worldwide. HPV vaccination is a primary prevention toolagainst HPV infection, thus the 
need to assess the knowledge, attitude and uptake of  HPV vaccination among female medical and dental students. 
Methodology
A descriptive cross sectional study was carried out among all undergraduatefemale medical and dental students in the 
University of  Benin. Data was collected using a pretested, semi-structured, self-administered questionnaire. The 
questionnaires comprised ofsocio-demographic characteristics, knowledge of  HPV vaccination, attitudes towards 
HPV vaccination and uptake of  HPV vaccination
Results
Two hundred and eighty questionnaires were administered however only 215 returned their completed questionnaires 
giving a response rate of  76.7%.The mean age of  respondents was 22.4 ± 3.0 years.Only about a third of  the 
respondents (31.2%) had a good knowledge of  HPV infection andvaccination. Age (p = 0.001), faculty (p = 0.014) 
and level of  study (p = 0.014) was observed to be significant determinants of  knowledge. A higher proportion of  
respondents (61.8%) had a positive attitude towards HPV vaccination while only a few (3.7%) had taken the HPV 
vaccine.Significant determinants of  attitude towards HPV vaccination were age (p = 0.001), faculty (p = 0.014), level 
of  study (p = 0.001) and knowledge (p = 0.031) of  respondents. Uptake of  HPV vaccination was significantly 
associated with attitude of  respondents (p = 0.001).
Conclusion
The knowledge and uptake of  HPV vaccination among these students was generally poor though most of  them had 
positive attitude towards HPV vaccination. This emphasizes the need for educational interventions to improve 
knowledge which will in turn enhance uptake.
INTRODUCTION
Human papilloma virus (HPV) infection is 
implicated in the cause of  cervical dysplasia and 
1,2
cancer as well as genital warts. Cervical cancer is 
the second most common cancer in women 
worldwide and also the third leading cancer 
2-4 worldwide irrespective of  gender. More than 
eighty percent of  the 274,000 deaths resulting from 
cervical cancer each year, occur in developing 
countries, and this proportion is expected to 
5
increase to 90% by 2020. Beyond cervical cancer, 
HPV is etiologically associated with 90 -93% ofcases 
of  cancer of  the anus, 12-63%  of  cases of  cancer 
of  the oropharynx, 36 -40% of  cases of  cancer of  
the penis, 40 -64% of  cases of  cancer of  the vagina 
6and 40 -51% of  cases of  cancer of  the vulva.
 HPV vaccination is a primary prevention tool 
against the two most prevalent oncogenic strains of  
HPV(16 and 18) which are responsible for about 
70% of  cervical cancer worldwide. However, 
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screening later in life is recommended as HPV types 
other than 16 and 18 are responsible for  up to 30% 
7
of  all cases.  The vaccine appears to have partial 
efficacy against infections caused by HPV types 31 
and 45 which are genetically related to type 16 and 
8,918. Vaccinating girls and women before their 
sexual debut or those who are naïve to these two 
7
strains has potential to reduce the burden by 70%.  
Modeling studies have shown that if  fully 
implemented, vaccination may lead to 66% 
reduction in pre-cancerous lesions which translate 
10to about 76% decline in cervical cancer deaths. In 
Nigeria, two vaccines, Gardasil-quadrivalent 
(Merck) and Cervarix-bivalent (GlaxoSmithKline) 
have being approved in line with the World Health 
Organization recommendation but still no national 
policy or programme to that effect. The 
recommended age range for routine immunization 
against HPV for females is 9 years to 26 years. 
Currently the vaccine is neither widely available nor 
11
affordable in Nigeria.
Knowledge of  cervical cancer, HPV infection and 
vaccine is fundamental to making informed 
decision as regards HPV vaccine acceptance.  
Several studies have documented poor knowledge 
and attitude towards HPV infection and vaccination 
as one of  the determinants of  vaccine uptake 
12, 13, 14
among females. There is paucity of  data on 
knowledge and attitude of  female medical students 
towards HPV infection and vaccination. However, 
amongst the few studies conducted among medical 
students knowledge gaps on HPV infection and 
4, 15
vaccine were observed. A study in South West, 
Nigeria among medical students reported good 
knowledge of  HPV infection among two-thirds of  
the respondents but poor knowledge on HPV 
16vaccination. Knowledge of  Physician's has also 
been shown to determine their recommendation of  
HPV vaccine, which has been reported by various 
17, 18, 19
studies as one of  the predictors of  HPV uptake.  
. Good knowledge and attitude towards HPV 
infection and vaccine among medical students and 
health care providers is essential to achieving a high 
level of  HPV vaccine uptake.This study focused on 
the knowledge, attitude and uptake of  HPV 
vaccination among female medical and dental 
undergraduates cognizant of  the fact that the study 
population are potential health workers and play a 
vital role in the dissemination of  health information 
to the general public. Also, the study population 
consists of  young females who are at higher risk of  
contracting HPV infection. Furthermore, the study 
findings will also provide baseline data necessary for 
the development of  training programs.
METHODOLOGY
A descriptive cross sectional study was conducted 
among female medical and dental studentsin the 
University of  Benin. The University of  Benin is 
located in the Benin metropolis which is the capital 
city of  Edo state. The School of  Medicine and 
Dentistry as at the time of  the study had 207 and 73 
females respectively spread across six levels. All 
female medical students in both the School of  
Medicine and Dentistry participated in the 
study.The study spanned over a 12 months period 
from September, 2012 to August, 2013.
Ethical clearance to conduct the study was obtained 
from the University of  Benin Teaching Hospital 
Ethical Committee. Approval to conduct the study 
was sought from the University authority and verbal 
informed consent was obtained from participants.
Method and Tool for data collection/ Data 
analysis
Quantitative method of  data collection was utilized 
with the aid of  pretested semi-structured, self-
administered questionnaires. The questionnaires 
focused on the following:Socio-demographic 
characteristics, knowledge of  HPV vaccination, 
attitudes towards HPV vaccination and uptake of  
HPV vaccination.Data collected was analyzed using 
IBM SPSS version 21 software. 
In scoring knowledge, one point was awarded for 
every correct answer and zero for incorrect or 'do 
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not know' responses. The total knowledge score 
was then converted into percentages and classified 
as follows. Poor knowledge score was a score ≤ 
49.9% , fair knowledge 50.0% to 69.9% and good 
knowledge was any score ≥ 70.0%.
A 5-point Likert scale ranging from “strongly 
disagree” to “strongly agree” was used in scoring 
attitudes toward the HPV vaccination. The scale 
consisted of  5 subscales including “safety 
concerns”, “perception of  needs”, “risky sexual 
behavior” ,“importance of  prevention” and  “ 
intentions to receive vaccination”. Five points was 
given to 'strongly disagree' responses, four points 
to 'disagree' responses, three points to 'no opinion' 
responses, two points to 'agree' responses and a 
point to 'strongly agree'. For negative questions the 
scoring system was reversed. The total attitude 
score was then converted into percentages and 
classified as follows: score of  50.0 to 100.0% 
represented a 'positive attitude', while 0% to 49.9% 
was adjudged 'negative attitude'. 
Univariate analysis was done for all variables. 
Bivariate analysis was done to determine 
association between age group, faculty of  
respondent and level of  study respectively with 
knowledge of  HPV, attitude towards HPV vaccine 
and practice of  HPV vaccination using the chi-
2
square (x ) test and the fisher's exact test where 
appropriate. p- value of  <0.05 was considered 
statistically significant.
RESULTS
Two hundred and eighty questionnaires were 
administered to all female medical and dental 
students in the study area, however only 215 
returned their completed questionnaires giving a 
response rate of  76.7%. 
One hundred and thirty three (61.9%) of  the 
respondents were within the age group of  20-24 years 
with a mean age of  22.4 ± 3.0 years. Respondents 
predominantly belonged to the faculty of  medicine 
176 (81.9%). Sixty five (30.2%) of  the respondents 
were in their pre-clinical level while 150 (69.8%) were 
in their clinical level. 
One hundred and eighty three respondents (85.1%) 
had heard of  human papilloma virus. Their source of  
information was mainly from school lectures 148 
(78.7%). All of  the respondents (100.0%) have heard 
of  cervical cancer and their source of  information 
was alsomainly from school lectures 144 (67.0%).
One hundred and eighteen (91.8%), 116 (63.4%) and 
54 (29.5%) of  the respondents had a correct 
knowledge that HPV cause cancer of  the cervix, can 
cause genital warts and cannot cause Herpes 
respectively.One hundred and fifty four respondents 
(84.2%) had a correct knowledge that a vaccine exist 
to prevent HPV infection/cancer of  the cervix while 
141 respondents (77.0%) had a correct knowledge 
that the vaccine is available in Nigeria. (Table I)
Table I: Knowledge of Respondents on HPV Infection and Vaccination
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A vaccine exists to prevent HPV 
infection/cancer of the cervix.
 
154(84.2) 3(1.6) 26(14.2)
The vaccine is available in Nigeria.
 
141(77.0) 2(1.1) 40(21.9)
One dose of the vaccine is enough to 
confer immunity against the virus.
 
46(25.1) 33(18.1) 104(56.8)
The HPV vaccine is very cheap.
 
82(44.8) 12(6.6) 89(48.6)
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Fifty seven respondents (31.2%) had an overall good 
knowledge while 65 (35.5%) had poor knowledge of  
HPV vaccination.(Table II)
One hundred and eighty two respondents (99.5%) 
had a positive attitude towards HPV vaccination while 
1 (0.5%) had a negative attitude respectively towards 
HPV vaccination. (TableIII)
 Only 8 (3.7%) of  the respondents had taken HPV 
vaccine and of  these only 2 (0.9%) had completed the 
dose. Also, among those that had received the vaccine 
50.0% had it before sexual debut and the other 50.0% 
after sexual debut. 
 The practice of  HPV vaccination was observed to 
increase with increasing knowledge however the 
association was not statistically significant. Also, 
practice of  HPV vaccination increased with positive 
attitude and this association was statistically 
significant. (Table IV)
DISCUSSION
Medical students are expected to have adequate 
knowledge on issues regarding health by virtue of  
their training to become future health care 
providers. Majority of  the respondents had heard 
of  HPV and its vaccination and school lectures 
were their main source of  information.Similar 
findings were seen among medical students in 
16 20 21South West, Nigeria , India and China.  This is 
not surprising as HPV is supposed to be part of  the 
medical curriculum. Contradictory findings were 
reported in similar studies among medical students 
where 30.0% in Southern Italy, 37.0% United 
States and 22.0% of  the respondents in South 
22 - 24Africawere aware of  HPV vaccination. All 
respondents had heard of  cervical cancer. This was 
in tandem with a study conducted in South West, 
Nigeria in which 95.4% of  the respondents had 
Table II: Predictors of Knowledge of HPV Infection and Vaccination 
among Respondents
 
Knowledge of HPV infection and vaccination    n (%)
Variable Poor Fair Good
Age group (years)
< 20 13 (72.2) 5 (27.8) 0 (0.0)
20-24 38 (32.8) 45 (38.8) 33 (28.4)
25-29  10 (21.3) 13 (27.7) 24 (51.0)
≥ 30   0  (0.0)  2 (100.0)   0  (0.0)






47 (31.1) 50 (33.1) 54 (35.8)
Dentistry
 
14 (43.8) 15 (46.9) 3 (9.3)
X
2






24 (68.6) 11 (31.4) 0 (0.0)
Clinical
 
37  (25.0) 54 (36.5)
X
2




61 (33.3) 65 (35.5)
Table III: Predictors of Attitude towards HPV Vaccination among 
Respondents
Attitude towards HPV Vaccination  n(%)
Variable Positive Negative
Age group (years)







≥ 30 2 (100.0)
 
 0 (0.0)












= 8.573, p = 0.014 
Level of study















Fair 65 (100.0) 0 (0.0)
Poor 57 (100.0) 0 (0.0)
Fisher’s exact = 8.786, p = 0.031
Total 182 (99.5) 1 (0.5)
 
Table IV: Predictors of Uptake of HPV Vaccination among 
Respondents.  
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Fisher’s exact =2.023, p = 0.395
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8  (4.4)     
 
174 (95.6)
Fisher’s exact = 169.824, p = 0.001        
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heard of  cervical cancer.
Only about a third of  respondents had a good 
knowledge of  HPVinfection and vaccination. This 
is in contrast with result from a study done in 
25 16Malaysia  and South West Nigeria which showed 
that62.9% and 67.1% of  the medical students 
respectively had good knowledge about HPV and its 
vaccination.However, findings were in line with that 
observed in a systematic review done in Sub- Sahara 
Africa which also showed low knowledge of  
26respondents on HPV and its vaccine. The observed 
knowledge gap in this study is a set back to HPV 
vaccination programmes especially as it regards 
health care providers in training. Knowledge of  
HPV among the studied population is of  utter most 
i m p o r t a n c e  a s  t h i s  m a y  i n f o r m  t h e i r 
recommendation to the entire public consequently 
hampering HPV vaccine uptake. This further 
reiterates the need for educational interventions to 
improve their knowledge on HPV infection and 
vaccine which will in turn improve HPV vaccine 
uptake.
The proportion of  respondents who had good 
knowledge of  HPV vaccination increased with 
increasing level of  study and the association was 
statistically significant. This finding is consistent 
with that in a study done in Turkey which showed a 
statistically significant association between the mean 
knowledge score of  HPV and the class of  the 
27students.  Also, others studies in Nigeria also 
16, 28,29showed significant association. This is expected 
as with increasing level of  study students are more 
exposed topractical and clinical aspect of  their 
training and more likely to have more in-depth 
knowledge. This implies that if  majority of  those 
with poor knowledge were in pre-clinical levels, 
hence their knowledge will be improved when they 
move to the clinical levels thereby attaining 
sufficient information to recommend HPV vaccine 
to their clients, consequently improving uptake.
A higher proportion of  respondents in the Faculty 
of  Medicine than those in Dentistry had good 
knowledge of  HPV vaccination and this association 
was statistically significant. This is in line with the 
findings from a study done in Malaysia which also 
showed a significant statistical association between 
total knowledge score and respondents in medicine 
24and dentistry. A possible explanationto this finding 
is that the curriculum of  the medical students 
addresses every aspect of  the body unlike the 
former which concentrates mainly on oral health. 
Information about HPV infection and vaccines 
should be incorporated into the curriculum of  
dental students so as to improve their knowledge 
because they also serve a vehicle in disseminating 
information to the general public.
Despite the fact that the knowledge of  HPV 
infection and vaccination was mainly poor, a higher 
proportion of  respondent had a positive attitude 
towards HPV vaccination. This could be the 
resultant effect of  presence of  childhood 
immunization which is universally known to prevent 
childhood diseases so one may infer that any new 
vaccine is important in preventing the targeted 
disease. Similar findings were observed in studies 
30 21carried out in UK  South Africa  and Lagos, 
31Nigeria  where 88.1%, 80.0% and 70.2% of  the 
respondents respectively were willing to accept 
HPV vaccination.
The proportion of  respondents who had a positive 
attitude towards HPV vaccination increased both 
with increasing level of  study and age. These 
associations were statistically significant. This could 
be explained because with increasing level of  study, 
there is more exposure to information concerning 
the disease which could translate to a better attitude 
towards its vaccination. 
Uptake of  HPV vaccination was low as onlya few 
respondents had received it. This finding is in 
accordance with results observed instudies done in 
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32 25USA  and Malaysia . Majority of  those vaccinated 
had good knowledge; one can infer that good 
knowledge translates to increased uptake. However, 
studies done in the Netherlands contradicts this 
33, 34findings. This low vaccination rate among the 
respondents despite a good attitude toward the 
vaccine could be because the vaccine was introduced 
in Nigeria in September 2008 and awareness is not 
yet optimal as evident by the poor knowledge. 
Alternatively low uptake may be the resultant effect 
of  cost as the vaccine is not given free unlike most 
childhood vaccines. 
Findings from this study indicate that since uptake 
was low among the respondents, HPV vaccination 
to their clients will be unlikely and this may be 
attributed to the poor knowledge observed in this 
study. Further study is recommended to identify 
other factors influencing uptake.This low uptake of  
HPV vaccination predisposes women to HPV 
infection which can otherwise be prevented by 
vaccination. This could in the long termlead to an 
increased prevalence of  HPV infection and its 
consequences. 
A possible limitation of  the study was recall bias as 
the study did not take into consideration the time 
lectures on cervical cancer, HPV infection and 
vaccination were rendered to the different 
categories of  students. In addition, the study did not 
address if  the students knew the information but 
f a i l ed  to  r emember  o r  neve r  knew the 
information.Furthermore, the cross-sectional 
nature of  the study also makes it difficult to 
conclude that knowledge was responsible for uptake 
bearing in mind that other factors may have 
influenced uptake.
In conclusion, gaps existed in knowledge and uptake 
of  HPV vaccination among medical students and 
this has to be addressed.Despite this, most of  the 
respondents were observed to have a positive 
attitude. There is need for more intense educational 
intervention as regards HPV infection and 
vaccination as well as its relation to cervical cancer in 
medical curriculum so as to improve knowledge 
which will in turn improve uptake and successful 
implementation of  HPV vaccination programmes.
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